Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

cbdMD (YCBD) Capital Expenditures: 2016-2025

Historic Capital Expenditures for cbdMD (YCBD) over the last 10 years, with Sep 2025 value amounting to $184,172.

  • cbdMD's Capital Expenditures fell 71.96% to $2,804 in Q3 2025 from the same period last year, while for Sep 2025 it was $184,172, marking a year-over-year decrease of 40.63%. This contributed to the annual value of $184,172 for FY2025, which is 3.08% down from last year.
  • According to the latest figures from FY2025, cbdMD's Capital Expenditures is $184,172, which was down 3.08% from $190,015 recorded in FY2024.
  • Over the past 5 years, cbdMD's Capital Expenditures peaked at $688,680 during FY2022, and registered a low of $184,172 during FY2025.
  • Its 3-year average for Capital Expenditures is $223,912, with a median of $190,015 in 2024.
  • In the last 5 years, cbdMD's Capital Expenditures plummeted by 74.09% in 2021 and then skyrocketed by 101.36% in 2022.
  • cbdMD's Capital Expenditures (MRY) stood at $342,013 in 2021, then surged by 101.36% to $688,680 in 2022, then crashed by 56.79% to $297,549 in 2023, then plummeted by 36.14% to $190,015 in 2024, then fell by 3.08% to $184,172 in 2025.
  • Its Capital Expenditures stands at $184,172 for FY2025, versus $190,015 for FY2024 and $297,549 for FY2023.